
Koninklijke Philips N.V. PHG
$ 27.08
-1.13%
Annual report 2024
added 12-06-2025
Koninklijke Philips N.V. EV/EBITDA Ratio 2011-2026 | PHG
Annual EV/EBITDA Ratio Koninklijke Philips N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 55.6 | 16.9 | 15.4 | 13.7 | 15.8 | 13.3 | 19.3 | 28.4 | 10 | 10.7 | 27.2 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.6 | 10 | 20.6 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 19.02 | 0.21 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 20.15 | -2.3 % | $ 217 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 0.17 | -6.7 % | $ 4.99 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
20.1 | $ 228.92 | -0.76 % | $ 167 B | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.53 | 2.0 % | $ 1.94 M | ||
|
DexCom
DXCM
|
39.5 | $ 66.37 | -1.03 % | $ 25.6 B | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 38.9 | -1.04 % | $ 1.08 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 11.38 | 6.36 % | $ 323 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 101.56 | -0.33 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 26.27 | -0.83 % | $ 794 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 18.84 | -1.21 % | $ 1.01 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 225.41 | -1.0 % | $ 40.9 B | ||
|
Celcuity
CELC
|
-2.38 | $ 99.74 | -0.18 % | $ 3.93 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 3.12 | - | $ 99.5 K | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
-28.8 | $ 102.14 | 1.53 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 4.53 | -4.83 % | $ 2.43 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 6.15 | -0.32 % | $ 557 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.76 | -3.84 % | $ 1.49 B | ||
|
Illumina
ILMN
|
70.5 | $ 131.16 | -1.2 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 199.48 | -1.24 % | $ 10.2 B | ||
|
National Research Corporation
NRC
|
21 | $ 18.77 | 0.64 % | $ 461 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 173.53 | -1.12 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 6.8 | 1.19 % | $ 882 M | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 250.88 | -0.87 % | $ 21 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 182.22 | -0.43 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 676.53 | -0.85 % | $ 55.8 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 66.55 | -0.91 % | $ 4.61 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 394.19 | -1.42 % | $ 29.6 B | ||
|
Precipio
PRPO
|
-1.8 | $ 22.98 | -1.84 % | $ 29.8 M | ||
|
Agilent Technologies
A
|
27.4 | $ 136.07 | -1.13 % | $ 41.4 B | ||
|
Personalis
PSNL
|
-7.07 | $ 7.96 | -0.13 % | $ 472 M | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.52 | 2.86 % | $ 5.79 M | ||
|
Bioventus
BVS
|
26.4 | $ 7.44 | -0.13 % | $ 466 M |